saplin

Baroda BNP Paribas Health and Wellness Fund

Baroda BNP Paribas Health and Wellness Fund (Direct, Growth): saplin Score 5.5/10 (Weak) among 14 Sectoral/Thematic funds. 1Y return 17.3%, expense ratio 1.55%. Better downside protection than most peers, but higher costs than most peers. NAV ₹11.34 on 11 Nov 2026.

Loading the full analysis…

Questions about Baroda BNP Paribas Health and Wellness Fund

What is the expense ratio of Baroda BNP Paribas Health and Wellness Fund?

The Direct plan's total expense ratio is 1.55% a year, against a median of 1.04% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages Baroda BNP Paribas Health and Wellness Fund?

Rohan Korde (since 1 May 2026); Ankeet Pandya (since 10 Jul 2026).

What are the top holdings of Baroda BNP Paribas Health and Wellness Fund?

Sun Pharmaceutical Industries 8.58%, Divi's Laboratories 8.41%, Torrent Pharmaceuticals 7.74%, Laurus Labs 7.56%, IPCA Laboratories 6.06% of the portfolio, as of 31 Oct 2026.

What returns has Baroda BNP Paribas Health and Wellness Fund given?

1 year: 17.3% (category median 21.9%). Past returns do not predict future ones.

How big is Baroda BNP Paribas Health and Wellness Fund?

About ₹511 cr (AMFI's average for the latest quarter).

How does Baroda BNP Paribas Health and Wellness Fund score?

5.5 out of 10 (Weak) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.